Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, Scotland.
Anne Rowling Regenerative Neurology Clinic, The University of Edinburgh, 49 Little France Crescent, Edinburgh, EH16 4SB, UK.
J Neurol. 2024 Aug;271(8):5083-5101. doi: 10.1007/s00415-024-12449-3. Epub 2024 May 28.
Motor neuron disease (MND) is a rapidly progressive condition traditionally assessed using a questionnaire to evaluate physical function, the revised amyotrophic lateral sclerosis functional rating scale (ALSFRS-R). Its use can be associated with poor sensitivity in detecting subtle changes over time and there is an urgent need for more sensitive and specific outcome measures. The ActiGraph GT9X is a wearable device containing multiple sensors that can be used to provide metrics that represent physical activity. The primary aim of this study was to investigate the initial suitability and acceptability of limb-worn wearable devices to group of people with MND in Scotland. A secondary aim was to explore the preliminary associations between the accelerometer sensor data within the ActiGraph GT9X and established measures of physical function. 10 participants with MND completed a 12-week schedule of assessments including fortnightly study visits, both in-person and over videoconferencing software. Participants wore the device on their right wrist and right ankle for a series of movements, during a 6-min walking test and for a period of 24-h wear, including overnight. Participants also completed an ALSFRS-R and questionnaires on their experience with the devices. 80% of the participants found wearing these devices to be a positive experience and no one reported interference with daily living or added burden. However, 30% of the participants experienced technical issues with their devices. Data from the wearable devices correlated with established measures of physical function.
运动神经元病(MND)是一种快速进展的疾病,传统上通过评估身体功能的问卷来进行评估,即修订后的肌萎缩侧索硬化功能评定量表(ALSFRS-R)。其使用可能与随时间推移检测细微变化的敏感性较差有关,因此迫切需要更敏感和更特异的结局测量指标。ActiGraph GT9X 是一种包含多个传感器的可穿戴设备,可用于提供代表身体活动的指标。本研究的主要目的是调查苏格兰一组 MND 患者使用肢体可穿戴设备的初步适用性和可接受性。次要目的是探索 ActiGraph GT9X 内加速度计传感器数据与既定身体功能测量指标之间的初步关联。10 名 MND 参与者完成了为期 12 周的评估计划,包括每两周一次的研究访问,包括面对面和视频会议软件。参与者将设备佩戴在右腕和右脚踝上,进行一系列动作、6 分钟步行测试以及 24 小时佩戴,包括夜间。参与者还完成了关于设备使用体验的 ALSFRS-R 和问卷。80%的参与者认为佩戴这些设备是一种积极的体验,没有人报告对日常生活造成干扰或增加负担。然而,30%的参与者遇到了设备技术问题。可穿戴设备的数据与既定的身体功能测量指标相关。